All news from Anaesthesiology

Study discovers, Protein-1 may determine bone loss responses to parathyroid hormone

Researchers from New York University College of Dentistry (NYU Dentistry) investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) showed, for the first time, that monocyte chemoattractant protein-1 (MCP-1) is required for catabolic responses to PTH. HTP is a condition in which an abnormally high concentration of PTH in the blood accelerates bone loss. The study was published in the Scientific Reports.